Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Apr;39(4):872–877. doi: 10.1128/aac.39.4.872

Erythromycin shortens neutrophil survival by accelerating apoptosis.

K Aoshiba 1, A Nagai 1, K Konno 1
PMCID: PMC162645  PMID: 7785987

Abstract

Erythromycin is reported to have an anti-inflammatory action, which may account for its clinical effectiveness in the treatment of chronic inflammatory diseases such as diffuse panbronchiolitis. To evaluate the anti-inflammatory action of erythromycin, we examined the survival of isolated neutrophils with and without erythromycin. Erythromycin shortened neutrophil survival in a dose-dependent fashion, with a maximum effect at 10 micrograms/ml [corrected] and above. Survival at 24 h was 63.4% in medium with 10 micrograms of erythromycin per ml compared with 82.7% in control medium (P < 0.01). This shortening of survival was brought about by acceleration of apoptosis, as evidenced by transmission electron microscopy. In a manner similar to that of erythromycin, other macrolide antibiotics, i.e., clarithromycin, roxithromycin, and midecamycin, also shortened neutrophil survival, but neither the beta-lactams ampicillin and cefazolin nor the aminoglycoside gentamicin affected their survival. Erythromycin increased intracellular levels of cyclic AMP (cAMP) to 150% of control levels in neutrophils. Forskolin, rolipram, and dibutyryl-cAMP, which are known to increase intracellular cAMP levels, also shortened neutrophil survival. H-89, an inhibitor of cAMP-dependent protein kinase A, partially blocked the survival-shortening effect of erythromycin. Our findings suggest that erythromycin shortens neutrophil survival at least in part through elevation of intracellular cAMP levels.

Full Text

The Full Text of this article is available as a PDF (513.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis. 1989 May;159(5):966–973. doi: 10.1093/infdis/159.5.966. [DOI] [PubMed] [Google Scholar]
  2. Anderson R., Fernandes A. C., Eftychis H. E. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes. J Antimicrob Chemother. 1984 Jul;14(1):41–50. doi: 10.1093/jac/14.1.41. [DOI] [PubMed] [Google Scholar]
  3. Anderson R., Glover A., Rabson A. R. The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. J Immunol. 1977 May;118(5):1690–1696. [PubMed] [Google Scholar]
  4. Dalziel K., Dykes P. J., Marks R. The effect of tetracycline and erythromycin in a model of acne-type inflammation. Br J Exp Pathol. 1987 Feb;68(1):67–70. [PMC free article] [PubMed] [Google Scholar]
  5. Domae M., Yamada K., Inoue T., Satoh M., Furukawa T. Endothelins stimulate cyclic AMP accumulation in the isolated rat anterior pituitary gland: possible involvement of ETA receptor activation and prostaglandin E2 production. J Pharmacol Exp Ther. 1994 Jul;270(1):55–60. [PubMed] [Google Scholar]
  6. Esterly N. B., Furey N. L., Flanagan L. E. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol. 1978 Jan;70(1):51–55. doi: 10.1111/1523-1747.ep12543487. [DOI] [PubMed] [Google Scholar]
  7. Fietta A., Bersani C., Santagada T., Bertoletti R., Gialdroni Grassi G. In vitro activity of macrolides on human phagocytic functions. Chemioterapia. 1987 Feb;6(1):52–56. [PubMed] [Google Scholar]
  8. Hand W. L., Hand D. L., King-Thompson N. L. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1990 May;34(5):863–870. doi: 10.1128/aac.34.5.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hand W. L., King-Thompson N. L., Steinberg T. H. Interactions of antibiotics and phagocytes. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):1–11. doi: 10.1093/jac/12.suppl_c.1. [DOI] [PubMed] [Google Scholar]
  10. Haslett C., Guthrie L. A., Kopaniak M. M., Johnston R. B., Jr, Henson P. M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol. 1985 Apr;119(1):101–110. [PMC free article] [PubMed] [Google Scholar]
  11. Hill H. R., Estensen R. D., Quie P. G., Hogan N. A., Goldberg N. D. Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism. 1975 Mar;24(3):447–456. doi: 10.1016/0026-0495(75)90124-9. [DOI] [PubMed] [Google Scholar]
  12. Ichikawa Y., Koga H., Tanaka M., Nakamura M., Tokunaga N., Kaji M. Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis. Chest. 1990 Oct;98(4):917–923. doi: 10.1378/chest.98.4.917. [DOI] [PubMed] [Google Scholar]
  13. Ichikawa Y., Ninomiya H., Koga H., Tanaka M., Kinoshita M., Tokunaga N., Yano T., Oizumi K. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis. 1992 Jul;146(1):196–203. doi: 10.1164/ajrccm/146.1.196. [DOI] [PubMed] [Google Scholar]
  14. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., Kawakami K., Fukushima K., Hiratani K., Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993 Jan;147(1):153–159. doi: 10.1164/ajrccm/147.1.153. [DOI] [PubMed] [Google Scholar]
  15. Kizaki H., Suzuki K., Tadakuma T., Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavage. J Biol Chem. 1990 Mar 25;265(9):5280–5284. [PubMed] [Google Scholar]
  16. Labro M. T., el Benna J., Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother. 1993 Mar;31 (Suppl 100):51–64. doi: 10.1093/jac/31.suppl_c.51. [DOI] [PubMed] [Google Scholar]
  17. Malech H. L., Gallin J. I. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987 Sep 10;317(11):687–694. doi: 10.1056/NEJM198709103171107. [DOI] [PubMed] [Google Scholar]
  18. May C. D., Levine B. B., Weissmann G. Effects of compounds which inhibit antigenic release of histamine and phagocytic release of lysosomal enzyme on glucose utilization by leukocytes in humans. Proc Soc Exp Biol Med. 1970 Mar;133(3):758–763. doi: 10.3181/00379727-133-34559. [DOI] [PubMed] [Google Scholar]
  19. McConkey D. J., Orrenius S., Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol. 1990 Aug 15;145(4):1227–1230. [PubMed] [Google Scholar]
  20. Miyachi Y., Yoshioka A., Imamura S., Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol. 1986 Apr;86(4):449–453. doi: 10.1111/1523-1747.ep12285793. [DOI] [PubMed] [Google Scholar]
  21. Nelson S., Summer W. R., Terry P. B., Warr G. A., Jakab G. J. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am Rev Respir Dis. 1987 Nov;136(5):1207–1212. doi: 10.1164/ajrccm/136.5.1207. [DOI] [PubMed] [Google Scholar]
  22. Nielson C. P. Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol. 1987 Oct 1;139(7):2392–2397. [PubMed] [Google Scholar]
  23. Nielson C. P., Vestal R. E. Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3': 5'-adenosine monophosphate, and intracellular calcium. Br J Pharmacol. 1989 Jul;97(3):882–888. doi: 10.1111/j.1476-5381.1989.tb12028.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Plewig G., Schöpf E. Anti-inflammatory effects of antimicrobial agents: an in vivo study. J Invest Dermatol. 1975 Dec;65(6):532–536. doi: 10.1111/1523-1747.ep12610281. [DOI] [PubMed] [Google Scholar]
  25. Savill J. S., Wyllie A. H., Henson J. E., Walport M. J., Henson P. M., Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest. 1989 Mar;83(3):865–875. doi: 10.1172/JCI113970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schrier D. J., Imre K. M. The effects of adenosine agonists on human neutrophil function. J Immunol. 1986 Nov 15;137(10):3284–3289. [PubMed] [Google Scholar]
  27. Schudt C., Winder S., Forderkunz S., Hatzelmann A., Ullrich V. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):682–690. doi: 10.1007/BF00174752. [DOI] [PubMed] [Google Scholar]
  28. Takeyama K., Tamaoki J., Chiyotani A., Tagaya E., Konno K. Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in-vitro. J Pharm Pharmacol. 1993 Aug;45(8):756–758. doi: 10.1111/j.2042-7158.1993.tb07104.x. [DOI] [PubMed] [Google Scholar]
  29. Washington J. A., 2nd, Wilson W. R. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). Mayo Clin Proc. 1985 Mar;60(3):189–203. doi: 10.1016/s0025-6196(12)60219-5. [DOI] [PubMed] [Google Scholar]
  30. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  31. Whyte M. K., Meagher L. C., MacDermot J., Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol. 1993 Jun 1;150(11):5124–5134. [PubMed] [Google Scholar]
  32. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES